Anthony Hollander

Title: Innovations of Anthony Hollander in Peptide Technology

Introduction

Anthony Hollander is a prominent inventor based in Liverpool, GB. He has made significant contributions to the field of peptide technology, particularly in the development of peptides and conjugates that have potential medical applications. His work is recognized for its innovative approach to targeting specific biological processes.

Latest Patents

Hollander holds a patent for "Peptides and conjugates," which includes peptides and conjugates comprising targeting peptides and payloads. The peptides consist of multiple modules corresponding to at least one of the modules of the collagen binding domain of a gelatinase, or a gelatin-binding fragment or variant thereof. The gelatinase may be MMP-2. The conjugates can be either therapeutic or non-therapeutic. His patent also covers the medical uses of these peptides or therapeutic conjugates, as well as pharmaceutical compositions that include them, along with nucleic acids encoding the peptides. This patent highlights his innovative approach to addressing medical challenges through peptide technology.

Career Highlights

Anthony Hollander is affiliated with the University of Liverpool, where he has been involved in various research initiatives. His work at the university has allowed him to explore the potential of peptides in therapeutic applications, contributing to advancements in medical science. His dedication to research and innovation has positioned him as a key figure in his field.

Collaborations

Due to space constraints, the details of collaborations will not be included.

Conclusion

Anthony Hollander's contributions to peptide technology through his patent demonstrate his innovative spirit and commitment to advancing medical science. His work continues to inspire future research in this important area.